PF-Atlas › Clinical Trials › NCT05016817
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF
AlloRx · Phase 1
Registry ID
NCT05016817
Phase
Phase 1
Status
Recruiting
Drug / intervention
AlloRx
Sponsor
The Foundation for Orthopaedics and Regenerative Medicine
Start
2022-07-03
Enrollment
20
Locations
1
About this trial
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Idiopathic pulmonary fibrosis
Explore related
Medical disclaimer. This page summarizes public trial data for NCT05016817 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.